Leadership Lessons is a monthly column from executives and thought leaders regarding best practices they use at their organizations to develop managers and leaders at all levels of the organization.
“Superbosses” are known in their industries not merely for their innovation and financial success, but for spawning a generation of leaders.
Bigger might not be better when it comes to getting access to more diverse perspectives.
For 30 years I have been researching midsized, little-known global market leaders. I often observe five common traits in these leaders.
A big part of the innovation challenge for large pharma companies is that while researchers are very good at technical innovation, the business end is not.
It’s easy to say we value different perspectives. It is quite another thing to really mean it, especially when it comes to views that feel dangerous, unscientific, and just plain wrong.
Here’s what employers concerned about healthcare, and for that matter, productivity and employee retention, need to do.
For life science leaders who manage diverse teams, with members spanning geographic, disciplinary, and even organization boundaries, here are some powerful leadership practices that help improve innovation.
The next evolution of leadership may be navigating paradox, which means learning to adapt rather than managing paradox which finds a solution.
Why is it so difficult for leaders to discuss personal accountability? The closer it gets to the leaders of the company, the more it may be avoided.
Serial breakthrough innovators have some interesting commonalities that serve up some important lessons for how we can unleash the breakthrough innovation potential in us all. Here are three of them.
How do today’s healthcare executives stay focused on the right things, productive in the face of immense pressure and competing demands, and proactive and strategic in the way they lead? It all starts with taking a pause.
The pharmaceutical and healthcare industries are at a crossroads, with the traditional business models experiencing what some have described as “fatigue.” Like many other industries facing profound shifts, this creates the imperative to bring together the disparate fields of competitive strategy, innovation, and organizational change.
Innovation and rules may seem like an odd couple. Aren’t innovators rule breakers, people who are willing — even eager — to challenge the status quo? For the most part, they are. Yet innovations rarely result from a genius having a single flash of insight. Instead, they emerge from a collaborative process of individuals with diverse perspectives generating a portfolio of ideas, testing and refining them, and finally, choosing a solution — most often one that combines seemingly competing ideas.
John, an exemplary employee, was promoted into a key management position. He wanted to address the team he would now be leading and gathered the group together in a training room. The new leader’s boss was part of the assembled group.
Rob Wright shares a personal anecdote about his experience of breaking into the biopharmaceutical industry, along with insight from three biopharma CEOs on what can be done to save the industry’s
Liz Barrett, CEO of Novartis Oncology, discusses taking a proactive approach toward mentoring tomorrow’s leaders.
Novartis Oncology CEO, Liz Barrett, on career advancement and family, a common challenge for women in the workplace.
Rob Wright shares what makes the CNS Summit the best conference he has ever attended.
What sets the Netherlands biopharma sector apart from the rest of the world? That’s what Chief Editor Rob Wright hoped to find out as he began his press tour of the country’s biopharma industry.